JohnMcleodGriffissMD
Infectious Disease • San Francisco, CAProfessor of Laboratory Medicine and Medicine
Dr. Griffiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 Clement St
111w1
San Francisco, CA 94121Phone+1 415-476-5371
Education & Training
University of WashingtonResidency, Internal Medicine, 1967 - 1968- University of WashingtonInternship, Internal Medicine, 1966 - 1967
Yale School of MedicineClass of 1966
Certifications & Licensure
OH State Medical License 2009 - 2027
CA State Medical License 1990 - 2026
MD State Medical License 2008 - 2026
MA State Medical License 1980 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Duration of Effect of Acidform Gel on Vaginal pH Start of enrollment: 2016 Aug 24
- Multiple Treatments for Ebola Virus Disease (EVD) Start of enrollment: 2015 Apr 01
Roles: Study Chair, Contact
Publications & Presentations
PubMed
- 5 citationsDosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Ph...George A Yendewa, John McLeod Griffiss, Wesley A Gray, Amanda Healen, Howard M Proskin
Antibiotics. 2022-04-06 - 8 citationsDevelopment and validation of an LC-MS/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasmaWesley A. Gray, Byron Waldorf, Manasa Geeta Rao, Brenda L. Stiles, J. McLeod Griffiss
Journal of Pharmaceutical and Biomedical Analysis. 2019-11-30 - 19 citationsImpact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.Amanda M. Healan, J. McLeod Griffiss, Howard M. Proskin, Mary Ann O'Riordan, Wesley A. Gray
Antimicrobial Agents and Chemotherapy. 2017-12-21
Grant Support
- Risk Factors And Susceptibility In Gonococcal InfectionNational Institute Of Allergy And Infectious Diseases2007–2011
- A Meningococcal LOS VaccineNational Institute Of Allergy And Infectious Diseases2003–2009
- Immunochemistry Of Gonococcal LipooligosaccharideNational Center For Research Resources2004–2006
- Immunochemistry Of Gonococcal LipopolysaccharideNational Institute Of Allergy And Infectious Diseases1999–2003
- Structural Studies Of LOS From Neisseria GonorrhoeaeNational Center For Research Resources1998–2002
- Immunochemistry Of Gonococcal LipopolysaccharideNational Institute Of Allergy And Infectious Diseases1985–1997
- The Role Of IGA In Bacterial DiseaseNational Institute Of Allergy And Infectious Diseases1985–1993
- Role Of IGA In Bacterial DiseaseNational Institute Of Allergy And Infectious Diseases1989–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
